AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

PALI · NASDAQ · Biotechnology

Palisade Bio (PALI)

Develops a once-daily oral PDE4 prodrug for ulcerative colitis and Crohn's disease.

$2.04

Pre-market+0.04 (+2.26%)

At close$2.00(+1.79%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions95 holders · as of Mar 31, 2026	85.78%	149.49M shares
Insiders6 holders · as of Aug 21, 2026	1.34%	2.34M shares
Otherremainder	12.88%	22.45M shares

174.27M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Ameriprise Financial IncInstitution	6.60%	11.51M	13Fas of Mar 31, 2026
B Group, Inc.Institution	6.55%	11.41M	13Fas of Mar 31, 2026
Janus Henderson Group PLCInstitution	6.13%	10.69M	13Fas of Mar 31, 2026
Octagon Capital Advisors LPInstitution	5.90%	10.28M	13Fas of Mar 31, 2026
Soleus Capital Master Fund, L.P.Institution	5.37%	9.35M	13Gfiled May 27, 2026 ↗
Perceptive Advisors LLCInstitution	5.12%	8.93M	13Fas of Mar 31, 2026
Commodore Capital LPInstitution	4.12%	7.18M	13Fas of Mar 31, 2026
Ra Capital Management, L.P.Institution	4.09%	7.12M	13Fas of Mar 31, 2026
Franklin Resources IncInstitution	3.32%	5.79M	13Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution	3.08%	5.37M	13Fas of Mar 31, 2026
Eversept Partners, LPInstitution	2.86%	4.99M	13Fas of Mar 31, 2026
Boxer Capital Management, LLCInstitution	2.75%	4.80M	13Fas of Mar 31, 2026
Morgan StanleyInstitution	2.61%	4.55M	13Fas of Mar 31, 2026
Adage Capital Partners GP, L.L.C.Institution	2.58%	4.50M	13Fas of Mar 31, 2026
Great Point Partners LLCInstitution	1.95%	3.41M	13Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution	1.88%	3.27M	13Fas of Mar 31, 2026
Federated Hermes, Inc.Institution	1.80%	3.14M	13Fas of Mar 31, 2026
Squadron Capital Management LLCInstitution	1.72%	3.00M	13Fas of Mar 31, 2026
Wellington Management Group LLPInstitution	1.67%	2.90M	13Fas of Mar 31, 2026
Marshall Wace, LLPInstitution	1.58%	2.75M	13Fas of Mar 31, 2026
Vestal Point Capital, LPInstitution	1.43%	2.50M	13Fas of Mar 31, 2026
Orbimed Advisors LLCInstitution	1.34%	2.33M	13Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution	1.30%	2.26M	13Fas of Mar 31, 2026
Millennium Management LLCInstitution	1.21%	2.10M	13Fas of Mar 31, 2026
Highvista Strategies LLCInstitution	1.16%	2.02M	13Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

95 holders · 149.49M shares · 31 new positions · 61 increased · 25 reduced · 22 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Ameriprise Financial Inc	11.51M	6.60%	+4.60M	Jul 17, 2026
B Group, Inc.	11.41M	6.55%	+6.91M	May 15, 2026
Janus Henderson Group PLC	10.69M	6.13%	+149.1K	May 18, 2026
Octagon Capital Advisors LP	10.28M	5.90%	+708.4K	May 15, 2026
Perceptive Advisors LLC	8.93M	5.12%	−3.12M	May 29, 2026
Commodore Capital LP	7.18M	4.12%	−4.26M	May 15, 2026
Ra Capital Management, L.P.	7.12M	4.09%	0	May 15, 2026
Franklin Resources Inc	5.79M	3.32%	+692.6K	May 13, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Janus Henderson Group PLC	9.99%	14.89M	13G	Dec 8, 2025 ↗
Armistice Capital, LLC	9.99%		13G	May 15, 2025 ↗
Steven Boydincl. Armistice Capital, LLC	9.99%			Nov 14, 2024 ↗
RA Capital Management, L.P.	9.90%	17.62M	13G	May 15, 2026 ↗
Perceptive Advisors LLC	7.90%	14.11M	13G	May 15, 2026 ↗
Commodore Capital LP	7.20%	12.37M	13G	May 15, 2026 ↗
Octagon Capital Advisors LP	6.40%	9.57M	13G	Feb 10, 2026 ↗
BlackRock, Inc.	6.00%	10.44M	13G	Jul 29, 2026 ↗
Franklin Resources, Inc.	6.00%	9.16M	13G	Jan 29, 2026 ↗
Soleus Capital Master Fund, L.P.	5.40%	9.35M	13G	May 27, 2026 ↗
Ameriprise Financial, Inc.	5.30%	8.71M	13G	May 15, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jul 8, 2026	Robert Jr. Balteradirector	Purchase	20,000	$1.99	436,904
Jul 9, 2026	Robert Jr. Balteradirector	Purchase	25,000	$1.96	461,904
Jul 7, 2026	John David Finleydirector, officer: CEO, CFO	Sale	146,798	$2.07	217,555
Jul 7, 2026	Mitchell Lawrence Jonesofficer: Chief Medical Officer	Sale	51,880	$2.05	94,009
Jul 6, 2026	Robert Jr. Balteradirector	Purchase	20,000	$2.05	386,904
Jul 7, 2026	Robert Jr. Balteradirector	Purchase	30,000	$2.03	416,904
Jul 1, 2026	Robert Jr. Balteradirector	Purchase	20,000	$1.98	356,904
Jul 2, 2026	Robert Jr. Balteradirector	Purchase	10,000	$1.98	366,904
Feb 12, 2026	John David Finleydirector, officer: CEO, CFO	Sale	3,896	$1.75	27,353
Feb 12, 2026	Mitchell Lawrence Jonesofficer: Chief Medical Officer	Sale	1,989	$1.75	13,263

CongressHouse and Senate disclosures

Not reported.